Genomics and transcriptomic alterations of the glutamate receptors in acute myeloid leukemia
Abstract Glutamine and glutamate have been widely explored as potential therapeutic targets in acute myeloid leukemia (AML). In addition to its bioenergetic role in leukemia cell proliferation, L‐glutamate is a neurotransmitter that acts on glutamate receptors. However, the role of glutamate recepto...
Main Authors: | Amani Alqahtani, Mengxi Wang, Mimi Lou, Houda Alachkar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-10-01
|
Series: | Clinical and Translational Science |
Online Access: | https://doi.org/10.1111/cts.13588 |
Similar Items
-
Features of the TCR repertoire associate with patients' clinical and molecular characteristics in acute myeloid leukemia
by: Mateusz Pospiech, et al.
Published: (2023-10-01) -
Acute Myeloid Leukemia—Genetic Alterations and Their Clinical Prognosis
by: Francisco Alejandro Lagunas-Rangel, et al.
Published: (2016-07-01) -
Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients
by: Sachi Horibata
Published: (2019-11-01) -
Estrogen Receptors Alpha and Beta in Acute Myeloid Leukemia
by: Alessia Roma, et al.
Published: (2020-04-01) -
TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia
by: Ramy Rahmé, et al.
Published: (2023-04-01)